Table 2 Pathological and clinical characteristics of CC patient series
From: ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer
Variable | Frequency n (%) | |
|---|---|---|
Age (years) | ||
Mean | 72.2 | |
Range | 48–93 | |
Gender | ||
Female | 46/144 (31.9) | |
Male | 98/144 (68.1) | |
Tumor location | ||
Right colon | 79/144 (54.9) | |
Left colon | 65/144 (45.1) | |
Histologic type | ||
ADC NOS* | 125/144 (86.8) | |
Colloid | 18/144 (12.5) | |
SRCC** | 1/144 (0.7) | |
Differentiation grade | ||
Well differentiated | 118/144 (81.9) | |
Moderately-Poorly differentiated | 26/144 (18.1) | |
Tumor size (cm) | ||
Mean | 4.51 | |
Range | 1.5–13 | |
Lymph node involvement | ||
No | 81/144 (56.3) | |
Yes | 63/144 (43.8) | |
Stage | ||
II | 80/144 (55.6) | |
III | 64/144 (44.4) | |
Lymphatic vascular invasion | ||
Negative | 108/144 (75.0) | |
Positive | 36/144 (25.0) | |
Blood vessel invasion | ||
Negative | 102/144 (70.8) | |
Positive | 42/144 (29.2) | |
Perineural invasion | ||
Negative | 112/144 (77.8) | |
Positive | 32/144 (22.2) | |
Chemotherapy | ||
No | 53/144 (36.8) | |
Yes | 67/144 (60.4) | |
Not valuable | 4/144 (2.8) | |
Recurrence | ||
No | 116/144 (80.6) | |
Yes | 27/144 (18.8) | |
Not valuable | 1/144 (0.7) | |
Exitus | ||
No | 113/144 (78.5) | |
Yes | 31/144 (21.5) | |